- Home
- Our Research
- Clinical Trials
- Search Clinical Trials
- Home
- Our Research
- Clinical Trials
- Search Clinical Trials
Academic Institute
Status: Open Not Enrolling
Investigator: Neal Kleiman
Study Coordinator: Deena Victor
Phone: 713.441.4536
Brief Summary: To evaluate safety and effectiveness of the ACURATE Transfemoral Aortic Valve System for transcatheter aortic valve replacement (TAVR) in subjects with severe native aortic stenosis who are indicated for TAVR. Detailed Description: ... Read more >
Status: Enrolling
Investigator: Miguel Valderrabano
Study Coordinator: Aneesch Martin
Phone: 713.441.6548
Brief Summary: The objective of this trial is to evaluate the safety and effectiveness of the Amulet LAA occluder compared to NOAC therapy in patients with non-valvular AF at increased risk for ischemic stroke and who are recommended for long-term N... Read more >
Status: Enrolling
Investigator: Marvin Atkins
Study Coordinator: Padmaja Naik
Phone: 713.441.7386
The purpose of this study is to characterize the safety and effectiveness of the Medtronic Avalus Ultra aortic valve bioprosthesis in patients with aortic valve disease.... Read more >
Status: Enrolling
Investigator: Sachin Goel
Study Coordinator: Deena Victor
Phone: 713.441.4536
Brief Summary: The objective of this study is to evaluate the preliminary safety and effectiveness of the Cephea Mitral Valve System for the treatment of symptomatic patients with mitral regurgitation = Grade III in whom transcatheter therapy is dee... Read more >
Status: Open Not Enrolling
Investigator: Neal Kleiman
Study Coordinator: Deena Victor
Phone: 713.441.4536
The primary objective of the study is to evaluate the safety and effectiveness of the Medtronic CoreValve® System (MCS) in a subset of subjects excluded from the U.S. Extreme Risk Pivotal Trial population due to one or more additional co-morbidities,... Read more >
Status: Enrolling
Investigator: Neal Kleiman
Study Coordinator: Deena Victor
Phone: 713.441.4536
Brief Summary: To establish the safety and effectiveness of the Edwards PASCAL Transcatheter Valve Repair System in patients with degenerative mitral regurgitation (DMR) who have been determined to be at prohibitive risk for mitral valve surgery by ... Read more >
Status: Enrolling
Investigator: Sachin Goel
Study Coordinator: Tia McGaughy
Phone: 346.238.4576
The objective of ENVISION is to evaluate the safety and effectiveness of the Navitor Transcatheter Aortic Valve Implantation (TAVI) System for treating patients with symptomatic, severe native aortic stenosis who are considered intermediate or low ri... Read more >
Status: Enrolling
Investigator: Neal Kleiman
Study Coordinator: Deena Victor
Phone: 713.441.4536
Brief Summary: Obtain safety and effectiveness data to support indication expansion for the Medtronic TAVR System to include patients with moderate, symptomatic AS. Detailed Description: Multi-center, international, prospective, randomized study... Read more >
Status: Enrolling
Investigator: Sachin Goel
Study Coordinator: Tia McGaughy
Phone: 346.238.4576
Brief Summary: The objective of this randomized controlled trial (RCT) is to compare the clinical outcome of MitraClip™ device versus surgical repair in patients with severe primary MR who are at moderate surgical risk and whose mitral valve has bee... Read more >
Status: Open Not Enrolling
Investigator: Neal Kleiman
Study Coordinator: Tia McGaughy
Phone: 346.238.4576
The purpose of the study is to investigate the safety and efficacy of transcatheter aortic valve implantation (TAVI) in patients with severe, symptomatic Aortic Stenosis (AS) at intermediate surgical risk by randomizing patients to either Surgical Ao... Read more >
Status: Enrolling
Investigator: Michael Reardon
Study Coordinator: Yejide Oyewole
Phone: 346.238.2294
Brief Summary: To collect information about treatment for symptomatic severe Aortic Regurgitation (AR), which affects the aortic valve in the heart. Aortic regurgitation is a condition where aortic valve in the heart does not close tightly and allow... Read more >
Status: Enrolling
Investigator: Neal Kleiman
Study Coordinator: Tia McGaughy
Phone: 346.238.4576
Brief Summary: Multi-center, global, prospective, non-randomized, interventional, pre-market trial. All subjects enrolled with receive the study device. Inclusion Criteria: Moderate to severe or severe symptomatic mitral regurgitation Local sit... Read more >
Status: Enrolling
Investigator: Sachin Goel
Study Coordinator: Yejide Oyewole
Phone: 346.238.2294
This is a prospective multicenter clinical investigation designed to evaluate the safety and effectiveness of the TricValve® Transcatheter Bicaval Valve System for improving outcomes in symptomatic subjects with severe TR deemed by the local Heart Te... Read more >
Status: Open Not Enrolling
Investigator: Stephen Little
Study Coordinator: Padmaja Naik
Phone: 713.441.7386
Brief Summary: The primary objective of this trial is to demonstrate the safety and effectiveness of the TriClip device in improving clinical outcomes in symptomatic patients with severe tricuspid regurgitation (TR), who are at intermediate or great... Read more >
Status: Enrolling
Investigator: Sachin Goel
Study Coordinator: Tia McGaughy
Phone: 346.238.4576
Brief Summary: The objective of this early feasibility study is to gain early clinical insight into the performance of the Intrepid transcatheter tricuspid valve replacement (TTVR) system intended for transfemoral access to deliver a self-expanding ... Read more >